| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |